Medius Associates
Medius provides an unrivalled range of specialised business development training solutions to cater for all levels of learning. This range extends from client specific in house tutorials through open enrolment courses to the Pharmaceutical Licensing Group’s distance learning modular MSc course.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Being social – harnessing the power of social media
White Papers and Resources | August 14, 2017 | Porterhouse Medical Group
With around 2.8 billion people using social media today, it’s a powerful force – one that encompasses a broad spectrum of websites and applications. In addition to well-known websites like Facebook,...
Leading Edge bolsters its delivery team
Press Releases | August 11, 2017 | Lucid Group Communications Limited
After earlier announcements that Lucid Partners was growing its medical writing team, Leading Edge (a Lucid Group company) proudly announces that it is strengthening its delivery team.Francesca Worthington joined Leading Edge...
How to build an online medical information service that resonates with your customers
White Papers and Resources | August 9, 2017 | Blue Latitude Health
Sourcing medical information is a top challenge for healthcare professionals in 2017. Here, Blue Latitude Health Associate Consultant Jiayi Chen gives you the inside scoop on how to build a...
You know more about your audience than you think
White Papers and Resources | August 9, 2017 | Four Agency Worldwide
Our Digital Lead, Richard Springham, discusses the untapped resources of your digital tools and how they hold the key to targeting your audiences.
How will the NHS’s new medicines savings drive affect pharma?
White Papers and Resources | August 9, 2017 | Wilmington Healthcare
Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets
Pharma need to keep their ‘pull & push’ separate from their ‘inbound & outbound’
White Papers and Resources | August 8, 2017 | An agency called Owen
Is your pharma brand using the marketing terms ‘pull & push’ correctly?
A man walks into a surgery: The role of storytelling in pharma marketing
White Papers and Resources | August 4, 2017 | Life Healthcare Communications
Communicating through stories can make your brand messages more meaningful, memorable and persuasive
Embracing the demands of the empowered ‘consumer-savvy’ patient by Ann Generlich
White Papers and Resources | August 3, 2017 | Say Communications
Our access to information, which is now constantly at our fingertips and the explosion of new technologies has shifted the buying power to increasingly ‘consumer-savvy’ patients. These are patients who choose...
The Art of Agile Marketing
White Papers and Resources | August 3, 2017 | Anthill Agency
The industry knows that it needs become more responsive to its stakeholders. An agile approach – which quickly improves results through a process of rapid market feedback and response –...
Could ketamine be the next big thing in depression?
White Papers and Resources | August 3, 2017 | Blue Latitude Health
Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.